Search Within

Patrizia Mondello

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (12)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Sloan Kettering Institute Postdocs (38)
  2. Department of Medicine (24)
  3. Hematologic Malignancies, Division of (24)
  4. Center for Hematologic Malignancies (19)
  5. Lymphoma (16)
  6. Executive Committee, Center for Hematologic Malignancies (13)

More Groups

People
  1. Anas Younes (11)
  2. Gilles Salles (8)
  3. Venkatraman Seshan (8)
  4. Andrew Zelenetz (6)
  5. David Scheinberg (6)
  6. Elisa De Stanchina (6)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (9)
  6. 2019 (3)

More Years

Publications
  1. Blood (9)
  2. Blood Cancer Journal (3)
  3. Oncotarget (3)
  4. Annals of Hematology (2)
  5. Clinical Lymphoma, Myeloma and Leukemia (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (4)
  4. Impact Journals (3)
  5. Springer (3)
  6. Elsevier Inc. (2)

More Publishers

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Kinase regulation of human MHC class i molecule expression on cancer cells
    Journal Article

    Brea, E. J.; Oh, C. Y.; Manchado, E.; Budhu, S.; Gejman, R. S.; Mo, G.; Mondello, P.; Han, J. E.; Jarvis, C. A.; Ulmert, D.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • Lenalidomide in relapsed or refractory diffuse large B-cell lymphoma: Is it a valid treatment option?
    Journal Article

    Mondello, P.; Steiner, N.; Willenbacher, W.; Ferrero, S.; Ghione, P.; Marabese, A.; Pitini, V.; Cuzzocrea, S.; Mian, M.
    The Oncologist (2016)

    Fulltext@MSK | Save
  • Extranodal diffuse large B-cell lymphoma with monoclonal gammopathy: An aggressive and primary refractory disease responding to an immunomodulatory agent
    Journal Article

    Mondello, P.; Pitini, V.; Barresi, V.; Brea, E. J.; di Mirto, C.; Arrigo, C.; Cuzzocrea, S.; Mian, M.
    Experimental Hematology and Oncology (2016)

    Fulltext@MSK | Save
  • Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study
    Journal Article

    Mondello, P.; Steiner, N.; Willenbacher, W.; Wasle, I.; Zaja, F.; Zambello, R.; Visentin, A.; Mauro, E.; Ferrero, S.; Ghione, P.; more...
    Annals of Hematology (2016)

    Fulltext@MSK | Save
  • Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments?
    Journal Article

    Mondello, P.; Mian, M.; Pitini, V.; Cuzzocrea, S.; Sindoni, A.; Galletti, M.; Mandolfino, M.; Santoro, D.; Mondello, S.; Aloisi, C.; more...
    Current Oncology (2016)

    Fulltext@MSK | Save
  • 90 Y-ibritumomab tiuxetan: A nearly forgotten opportunity
    Journal Article

    Mondello, P.; Cuzzocrea, S.; Navarra, M.; Mian, M.
    Oncotarget (2016)

    Fulltext@MSK | Save
  • 90Y-ibritumomab-tiuxetan consolidation therapy for advanced-stage mantle cell lymphoma after first-line autologous stem cell transplantation: Is it time for a step forward?
    Journal Article

    Mondello, P.; Steiner, N.; Willenbacher, W.; Arrigo, C.; Cuzzocrea, S.; Pitini, V.; Mian, M.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Emerging drugs for diffuse large B-cell lymphoma
    Journal Article

    Mondello, P.; Younes, A.
    Expert Review of Anticancer Therapy (2015)

    Fulltext@MSK | Save